<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-36431" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Biochemistry, Transferrin</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ogun</surname>
            <given-names>Aminat S.</given-names>
          </name>
          <aff>Brooklyn Hospital Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Adeyinka</surname>
            <given-names>Adebayo</given-names>
          </name>
          <aff>The Brooklyn Hospital Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Aminat Ogun declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Adebayo Adeyinka declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>16</day>
          <month>11</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-36431.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Iron is vital for several metabolic pathways and physiological processes.<xref ref-type="bibr" rid="article-36431.r1">[1]</xref>&#x000a0;Maintaining iron homeostasis is essential as a change, either decrease or excess, harms the human body. Transferrin has a high affinity to ferric iron; therefore, there is little free iron in the body as transferrin binds, in essence, all plasma. Transferrin&#x000a0;is a blood plasma glycoprotein that plays a central role in iron metabolism and is responsible for ferric-ion delivery. Transferrin functions as the most critical ferric pool in the body. It transports iron through the blood to various tissues, such as the liver, spleen, and bone marrow. It is an essential biochemical marker of body iron status<bold>.</bold></p>
      </sec>
      <sec id="article-36431.s2" sec-type="Fundamentals">
        <title>Fundamentals</title>
        <p>Transferrin is divided into subgroups: serum transferrin, lactotransferrin, and melanotransferrin.<xref ref-type="bibr" rid="article-36431.r2">[2]</xref>&#x000a0;Hepatocytes produce serum transferrin, which is found in the serum, cerebrospinal fluid, and semen. Mucosal epithelial cells produce lactotransferrin, seen in bodily secretions such as milk. Lactotransferrin has antioxidants and antimicrobial and anti-inflammatory properties. All plasma iron is bound to transferrin.<xref ref-type="bibr" rid="article-36431.r3">[3]</xref>&#x000a0;The transferrin-bound iron complex turnover rate is about ten times a day, essential to meet the daily demands of erythropoiesis.<xref ref-type="bibr" rid="article-36431.r4">[4]</xref>&#x000a0;Therefore, transferrin acts as a balance between reticuloendothelial iron release and bone marrow uptake. Once iron is bound to transferrin, it is transported by transferrin to the bone marrow for the production of hemoglobin and portions of erythrocytes. The body loses iron through perspiration, epithelial cell desquamation, and menstruation. Iron loss is obligatory, and no specific means exist to regulate it. Therefore, iron homeostasis hugely depends on the tight regulation of absorption, which occurs mostly in the proximal intestine.<xref ref-type="bibr" rid="article-36431.r5">[5]</xref>&#x000a0;Iron-bound transferrin is vital for the distribution of iron to the body's different cells.&#x000a0;</p>
      </sec>
      <sec id="article-36431.s3" sec-type="Cellular Level&#x0000d;&#x0000a;">
        <title>Cellular Level
</title>
        <p>Transferrin is a free peptide (apotransferrin) that undergoes a conformation change after binding with iron. Iron circulates in the plasma until it attaches to a transferrin receptor on a target cell. A carbonate has to be present to help attract iron to transferrin by creating opposing repulsive charges. Transferrin can bind to two atoms of ferric iron (Fe<sup>3+</sup>) with high affinity. The carbonate needed also serves as a ligand to stabilize iron in the transferrin binding site. Clathrin/receptor-mediated endocytosis mediates the uptake of iron by transferrin receptors.<xref ref-type="bibr" rid="article-36431.r6">[6]</xref>&#x000a0;An acidic environment of Ph5.6 reduces iron-transferrin affinity, encouraging iron release from its binding site and endocytoses into a cell.<xref ref-type="bibr" rid="article-36431.r1">[1]</xref></p>
      </sec>
      <sec id="article-36431.s4" sec-type="Molecular Level&#x0000d;&#x0000a;">
        <title>Molecular Level
</title>
        <p>Transferrin is a monomeric 80kDA glycoprotein consisting of two homologous lobes called N- and C- lobes.<xref ref-type="bibr" rid="article-36431.r7">[7]</xref>&#x000a0;A short peptide connects the two lobes. The carbohydrate moiety is attached to the C-lobe. Each lobe is subdivided into two sub-domains- N1 and N2 for the N-lobe and C1 and C2 for the C-lobe. The sub-domains connect two antiparallel beta-sheets that act as flexible joints. The N and C lobes&#x000a0;comprise one aspartic acid, two tyrosine, a histidine, and an arginine.<xref ref-type="bibr" rid="article-36431.r8">[8]</xref>&#x000a0;Between each lobe forms a cleft, which allows iron binding. The transferrin molecule is shaped to permit iron binding. The sub-domains open to release iron and close when bound.</p>
      </sec>
      <sec id="article-36431.s5" sec-type="Function">
        <title>Function</title>
        <p>Functions of transferrin&#x000a0;include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Free Fe<sup>3+</sup> is insoluble at a neutral pH; when iron binds to transferrin, it becomes soluble.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Deliver and transfer iron to all the various biological tissues between sites of absorption, utilization, and storage.<xref ref-type="bibr" rid="article-36431.r9">[9]</xref></p>
          </list-item>
          <list-item>
            <p>Prevent the formation of reactive oxygen species.</p>
          </list-item>
          <list-item>
            <p>Chelate-free toxic iron and acts as a protective scavenger.</p>
          </list-item>
          <list-item>
            <p>Deliver WBC macrophages to all tissues<xref ref-type="bibr" rid="article-36431.r10">[10]</xref></p>
          </list-item>
          <list-item>
            <p>Transferrin is a part of the innate immune system; transferrin binding to iron impedes bacterial survival.</p>
          </list-item>
          <list-item>
            <p>Transferrin acts as a marker for inflammation; the transferrin level decreases during inflammation.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-36431.s6" sec-type="Mechanism">
        <title>Mechanism</title>
        <p>The offloading iron-bound transferrin begins with transferrin binding to its cell surface transferrin receptor. It starts with the formation of clathrin-coated pits and the internalization of the vesicle into the cytoplasm. The coated vesicle loses its clathrin coat due to a reduction in pH. The reduction of pH by hydrogen ion proton pumps (H<sup>+</sup> ATPase) to a pH of 5.5 causes the dissociation of iron-bound transferrin vesicle to release its iron ions. Also, transferrin binding to transferrin receptors reduces its affinity for iron. Two pathways can occur once endocytosed&#x02013;degradation or recycling pathways.<xref ref-type="bibr" rid="article-36431.r11">[11]</xref>&#x000a0;The degradation pathway is where the dissociation of ferric ions from transferrin occurs from an early and late endosome. Iron can now be utilized for storage or incorporated into hemoglobin. The recycling pathway involves the recycling of transferrin. After the dissociation of iron, transferrin is called apotransferrin. Apotransferrin remains bound to its receptor because it has a high affinity for its receptors at a reduced pH.<xref ref-type="bibr" rid="article-36431.r11">[11]</xref>&#x000a0;It recycles back to the plasma membrane, still bound to its receptor. At a neutral pH, apotransferrin dissociates from its receptor to enter the circulation, reload iron, and repeat the cycle. All transferrin receptors eventually follow the degradation pathway for receptor turnover. An example of a cell is an erythroid precursor in the bone marrow.&#x000a0;</p>
      </sec>
      <sec id="article-36431.s7" sec-type="Testing">
        <title>Testing</title>
        <p>The laboratory's reference range for transferrin is 204-360 mg/dL. Transferrin can assess the body's iron level and other markers. Transferrin level testing is used to determine the cause of anemia, examine iron metabolism, and determine the iron-carrying capacity of the blood. Transferrin saturation levels cannot be interpreted alone. They are used with other laboratory tests, such as serum ferritin and&#x000a0;total iron binding capacity. Ferritin is the first marker to become low and, therefore, more sensitive than transferrin in diagnosing iron deficiency anemia.<xref ref-type="bibr" rid="article-36431.r12">[12]</xref>&#x000a0;Total or transferrin iron-binding capacity is a test that measures the blood's capacity to bind iron with transferrin. Low transferrin saturation is seen in iron deficiency.&#x000a0;</p>
      </sec>
      <sec id="article-36431.s8" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Iron deficiency is recognized as the most prevalent nutritional deficit in the world. The amount of transferrin in the blood indicates the amount of iron in the body. High transferrin signifies low iron, which means there is less iron bound to transferrin, allowing for a high circulation of non-bound iron transferrin in the body, revealing a possible iron deficiency anemia. The liver increases the production of transferrin as a form of&#x000a0;homeostasis to enable transferrin to bind to iron and transport it to the cells. Upregulation of transferrin receptors occurs in iron deficiency anemia.<xref ref-type="bibr" rid="article-36431.r13">[13]</xref>&#x000a0; Concerning the percentage of transferrin-iron complex, low iron-bound transferrin indicates low iron levels in the body, which affects hemoglobin and erythropoiesis. The significance of transferrin is that it can detect iron deficiency and can be used to&#x000a0;monitor erythropoiesis. In anemia of chronic disease, there is a decreased transferrin level.&#x000a0;Causes of low transferrin:</p>
        <list list-type="bullet">
          <list-item>
            <p>Liver damage leads to reduced production of transferrin</p>
          </list-item>
          <list-item>
            <p>Kidney insult or injury leads to loss of transferrin in urine.</p>
          </list-item>
          <list-item>
            <p>Infection</p>
          </list-item>
          <list-item>
            <p>Malignancy</p>
          </list-item>
          <list-item>
            <p>Atransferrinemia: A genetic mutation resulting in the absence of transferrin, which leads to hemosiderosis in the heart and liver, which can lead to heart and liver failure. This condition is treated by plasma infusion.</p>
          </list-item>
        </list>
        <p>Low transferrin in plasma indicates iron overload, which means the binding site of transferrin is highly saturated with iron. Iron overload suggests hemochromatosis, which leads to iron deposition on tissues. Other associations with transferrin and its receptors include,</p>
        <list list-type="bullet">
          <list-item>
            <p>Diminishing tumor cells when the receptor is used to attract antibodies</p>
          </list-item>
          <list-item>
            <p>High transferrin saturation increases the risk of cardiovascular mortality if patients have high transferrin saturation (&#x0003e;55%) and LDL levels<xref ref-type="bibr" rid="article-36431.r14">[14]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-36431.s9">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=36431&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=36431">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/36431/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=36431">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-36431.s10">
        <title>References</title>
        <ref id="article-36431.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Steere</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Byrne</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Chasteen</surname>
                <given-names>ND</given-names>
              </name>
              <name>
                <surname>Mason</surname>
                <given-names>AB</given-names>
              </name>
            </person-group>
            <article-title>Kinetics of iron release from transferrin bound to the transferrin receptor at endosomal pH.</article-title>
            <source>Biochim Biophys Acta</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>1820</volume>
            <issue>3</issue>
            <fpage>326</fpage>
            <page-range>326-33</page-range>
            <pub-id pub-id-type="pmid">21699959</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36431.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wally</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Buchanan</surname>
                <given-names>SK</given-names>
              </name>
            </person-group>
            <article-title>A structural comparison of human serum transferrin and human lactoferrin.</article-title>
            <source>Biometals</source>
            <year>2007</year>
            <month>Jun</month>
            <volume>20</volume>
            <issue>3-4</issue>
            <fpage>249</fpage>
            <page-range>249-62</page-range>
            <pub-id pub-id-type="pmid">17216400</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36431.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Giansanti</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Panella</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Leboffe</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Antonini</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Lactoferrin from Milk: Nutraceutical and Pharmacological Properties.</article-title>
            <source>Pharmaceuticals (Basel)</source>
            <year>2016</year>
            <month>Sep</month>
            <day>27</day>
            <volume>9</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">27690059</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36431.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dautry-Varsat</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Receptor-mediated endocytosis: the intracellular journey of transferrin and its receptor.</article-title>
            <source>Biochimie</source>
            <year>1986</year>
            <month>Mar</month>
            <volume>68</volume>
            <issue>3</issue>
            <fpage>375</fpage>
            <page-range>375-81</page-range>
            <pub-id pub-id-type="pmid">2874839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36431.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anderson</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>YM</given-names>
              </name>
            </person-group>
            <article-title>Iron homeostasis in the liver.</article-title>
            <source>Compr Physiol</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>3</volume>
            <issue>1</issue>
            <fpage>315</fpage>
            <page-range>315-30</page-range>
            <pub-id pub-id-type="pmid">23720289</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36431.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Luck</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Mason</surname>
                <given-names>AB</given-names>
              </name>
            </person-group>
            <article-title>Transferrin-mediated cellular iron delivery.</article-title>
            <source>Curr Top Membr</source>
            <year>2012</year>
            <volume>69</volume>
            <fpage>3</fpage>
            <page-range>3-35</page-range>
            <pub-id pub-id-type="pmid">23046645</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36431.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wally</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Halbrooks</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Vonrhein</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rould</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Everse</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Mason</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Buchanan</surname>
                <given-names>SK</given-names>
              </name>
            </person-group>
            <article-title>The crystal structure of iron-free human serum transferrin provides insight into inter-lobe communication and receptor binding.</article-title>
            <source>J Biol Chem</source>
            <year>2006</year>
            <month>Aug</month>
            <day>25</day>
            <volume>281</volume>
            <issue>34</issue>
            <fpage>24934</fpage>
            <page-range>24934-44</page-range>
            <pub-id pub-id-type="pmid">16793765</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36431.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hall</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Hadden</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Leonard</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Bailey</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Neu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Winn</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lindley</surname>
                <given-names>PF</given-names>
              </name>
            </person-group>
            <article-title>The crystal and molecular structures of diferric porcine and rabbit serum transferrins at resolutions of 2.15 and 2.60 A, respectively.</article-title>
            <source>Acta Crystallogr D Biol Crystallogr</source>
            <year>2002</year>
            <month>Jan</month>
            <volume>58</volume>
            <issue>Pt 1</issue>
            <fpage>70</fpage>
            <page-range>70-80</page-range>
            <pub-id pub-id-type="pmid">11752780</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36431.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tandara</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Salamunic</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Iron metabolism: current facts and future directions.</article-title>
            <source>Biochem Med (Zagreb)</source>
            <year>2012</year>
            <volume>22</volume>
            <issue>3</issue>
            <fpage>311</fpage>
            <page-range>311-28</page-range>
            <pub-id pub-id-type="pmid">23092063</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36431.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gordon</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pl&#x000fc;ddemann</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Tissue macrophages: heterogeneity and functions.</article-title>
            <source>BMC Biol</source>
            <year>2017</year>
            <month>Jun</month>
            <day>29</day>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>53</fpage>
            <pub-id pub-id-type="pmid">28662662</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36431.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grant</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Donaldson</surname>
                <given-names>JG</given-names>
              </name>
            </person-group>
            <article-title>Pathways and mechanisms of endocytic recycling.</article-title>
            <source>Nat Rev Mol Cell Biol</source>
            <year>2009</year>
            <month>Sep</month>
            <volume>10</volume>
            <issue>9</issue>
            <fpage>597</fpage>
            <page-range>597-608</page-range>
            <pub-id pub-id-type="pmid">19696797</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36431.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Waldvogel-Abramowski</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Waeber</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gassner</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Buser</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Frey</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Favrat</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Tissot</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Physiology of iron metabolism.</article-title>
            <source>Transfus Med Hemother</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>41</volume>
            <issue>3</issue>
            <fpage>213</fpage>
            <page-range>213-21</page-range>
            <pub-id pub-id-type="pmid">25053935</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36431.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bermejo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-L&#x000f3;pez</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>A guide to diagnosis of iron deficiency and iron deficiency anemia in digestive diseases.</article-title>
            <source>World J Gastroenterol</source>
            <year>2009</year>
            <month>Oct</month>
            <day>07</day>
            <volume>15</volume>
            <issue>37</issue>
            <fpage>4638</fpage>
            <page-range>4638-43</page-range>
            <pub-id pub-id-type="pmid">19787826</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36431.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wells</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Mainous</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>King</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Gill</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Carek</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Geesey</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>The combined effect of transferrin saturation and low density lipoprotein on mortality.</article-title>
            <source>Fam Med</source>
            <year>2004</year>
            <month>May</month>
            <volume>36</volume>
            <issue>5</issue>
            <fpage>324</fpage>
            <page-range>324-9</page-range>
            <pub-id pub-id-type="pmid">15129378</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
